Search

everythinglearnresearchcommunity

for

Search:↓

The research found that PCOS has common genetic factors regardless of how it is diagnosed and is linked to metabolic and reproductive issues.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Better-designed, long-term studies are needed to optimize treatment for trichotillomania and trichophagia.

The document concludes that women with PCOS need a comprehensive care model that covers reproductive, metabolic, and psychological health to improve their quality of life.

Acne in reproductive-age women may be linked to conditions like PCOS and lifestyle factors, so doctors should check for these when treating acne.

Women with PCOS tend to be less optimistic than those without it.

The article concludes that better diagnosis and management of Polycystic Ovarian Syndrome are needed to improve women's health and prevent related diseases.

Venlafaxine can cause hair loss, which stops after discontinuation.

People with trichotillomania or skin picking disorder generally sleep worse than those without these conditions.

The guideline refines PCOS diagnosis, promotes a healthy lifestyle, reviews treatments, and stresses long-term follow-up.

Too much male hormone in mothers can negatively affect the sexual behavior of both male and female baby mice.

Depression and hair loss may influence each other.

Impulsiveness is common across various psychiatric disorders and linked to many psychological symptoms.

Treating both bipolar disorder and hair-related BDD with psychiatric medications improved the patient's symptoms.

Finasteride (Propecia) may cause depression and suicidal thoughts; stop use and inform a healthcare professional if symptoms develop.

Finasteride can cause side effects, some lasting after treatment ends, and may lead to severe depression or suicidal thoughts.

Iron deficiency is common in female military personnel but doesn't significantly impact daily physical activity.

Lithium treatment can cause increased hair shedding and hair loss in patients.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Women with skin conditions who have body image concerns often experience mental health issues and a lower quality of life.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

Finasteride side effects in young men may be linked to specific gene variations.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

The document concludes that individualized treatment and lifestyle changes are important for managing menopause symptoms and health risks.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Myo-inositol and D-chiro-inositol improve hormonal and physical symptoms in teenage girls with PCOS.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.